HI Japan 2019

WATCH: Nippon Flour Mills reveals new healthy ageing ingredient to prevent mobility-related disability

By Guan Yu Lim contact

- Last updated on GMT

Related tags: Japan, Healthy ageing, sarcopenia

Maslinic acid supplementation could be effective in preventing mobility-related disability like chronic knee pain, and muscle loss in elderly people.

At the recent HI Japan show in Tokyo, NutraIngredients-Asia​ spoke to Nippon Flour Mills’ Kouhei Kawaguchi to find out more about the company’s clinical trials on this ingredient in collaboration with the University of Hyogo.

One study published​ in 2017, found 16 weeks intake of maslinic acid (30mg/day) had a protective effect on chronic knee pain in elderly Japanese residents.

Another study revealed​ that maslinic acid supplementation (60mg/day) was found to improve muscle strength and mass in elderly, when combined with moderate resistance training.

These studies suggest that maslinic acid supplementation could be effective in preventing mobility-related disability in elderly people, and improve their quality of life.  

According to TPC marketing research in Japan, the number of people with locomotive symptoms or reduced mobility is 47 million in Japan, and market size is valued at JPY 135 billion.

Kawaguchi said maslinic acid is a relatively new ingredient in the Japan market that has shown effectiveness sufficient to meet Food with Function claims (FFC)

He said it can used in various food and supplements applications for its good heat and pH stability, as well as high bioavailability.

Watch the video find out more.

Related news

Show more

Related products

show more

MenaQ7® Vitamin K2: The Bone Support Solution

MenaQ7® Vitamin K2: The Bone Support Solution

NattoPharma USA, Inc. | 03-Sep-2020 | Data Sheet

Whether creating a product to fortify children’s bones as they grow or a formula to help adults stave off inevitable bone loss from ageing, MenaQ7® Vitamin...

cognitaven® boosts cognitive performance

cognitaven® boosts cognitive performance

Anklam Extrakt GmbH | 30-Aug-2020 | Clinical Study

Within the course of a randomised, double-blind, placebo-controlled study, the acute and chronic effects of green oat (Avena sativa) herb extract on cognitive...

Related suppliers

NutraIngredients-Asia Awards 2020

22nd September 2020, 3 pm SGT

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast